öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÌÀƽ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º57

ËùÊôԺУ£º¹ãÖÝÒ½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÍâ¿Æѧ


¸öÈ˼òÊö :
ÌÀƽ£¬ÄУ¬1973Äê³öÉú£¬ÃñÃËÃËÔ±£¬Ò½Ñ§²©Ê¿£¬ÃÀ¹úDuke´óѧǰÁÐÏÙ¼²²¡ÖÐÐIJ©Ê¿ºó£¨2008-2009Ä꣩£¬¹ãÖÝÊеÚÒ»ÈËÃñÒ½ÔºÃÚÄòÍâ¿ÆÖ÷ÈÎҽʦ£¬Ë¶Ê¿Éúµ¼Ê¦,¹ã¶«Ê¡ÃÚÄòÍâ¿ÆÖÐÇàÄêίԱ»á¡¢¹ã¶«Ê¡ÖÐÎ÷Ò½½áºÏÃÚÄòÍâ¿ÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¡¢¹ã¶«Ê¡¿¹°©öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áÃÚÄòÍâ¿Æ·Ö»áίԱ£¬¹ãÖÝÊÐÎÀÉú¾Ö¡¢¹ãÖÝÊеÚÒ»ÈËÃñÒ½ÔºÓÅÐã¿Æ¼¼È˲Å£¬¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿¡¢¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ðÆÀÉóר¼Ò¡£´ÓÊÂÃÚÄòÍâ¿ÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØ10ÓàÄ꣬ÁÙ´²ÉÏÒÔÃÚÄòÍâ¿Æ¸¹Ç»¾µ¡¢¾­ÄòµÀÇ°ÁÐÏÙµçÇÐÊõ£¨TURP£©¡¢¾­Æ¤Éö¾µÊõ£¨PCN£©µÈΪÖ÷µÄ΢´´ÊÖÊõΪÌØÉ«¡£2008Äê×÷Ϊ¹ãÖÝÊÐÎÀÉú¾ÖÖصãר¿ÆôßÃÚÄòÍâ¿ÆÊ×ÅúÈ˲ÅÅàÑøÈËÑ¡£¬±»ÅÉË͵½ÃÀ¹úÖøÃûµÄDuke´óѧǰÁÐÏÙ¼²²¡ÖÐÐÄѧϰ£¬ÔÚÇ°ÁÐÏÙ°©µÄÑо¿·½ÃæÈ¡µÃÁËÖØÒªµÄ³É¼¨¡£

¿ÆÑй¤×÷ :
Ö÷³Ö°üÀ¨¹ú¼Ò×ÔÈ»»ù½ð¡¢¹ã¶«Ê¡×ÔÈ»»ù½ð¡¢¹ãÖÝÊÐÎÀÉú¾ÖÖصãÏîÄ¿ÔÚÄÚµÄÇ°ÁÐÏÙ°©·½Ïò¿ÆÑпÎÌâ¹²6Ï×ܾ­·Ñ³¬¹ý100ÍòÔª£¬ÒÔµÚÒ»×÷ÕßÔÚÊÀ½çÃÚÄòÍâ¿ÆÖ÷Á÷ÔÓÖ¾ÉÏ·¢±íSCIÂÛÖø9ƪ£¬×ÜÓ°ÏìÒò×Ó½ü30·Ö£¬»ñµÃ¹ã¶«Ê¡¿Æ¼¼½ø²½ÈýµÈ½±¡¢¹ãÖÝÊпƼ¼½ø²½ÈýµÈ½±¸÷1Ï¾ùΪµÚ¶þÍê³ÉÈË£©¡£´ú±íÐÔÂÛÎÄ£¨¸½·¢±íµ±Äê»ò×îÐÂÓ°ÏìÒò×Ó£©1.?Tang?P,?Du?W,?Xie?K,?et?al.?Transition?zone?PSA?density?improves?the?prostate?cancer?detection?rate?both?in?PSA4.0-10.0?and?10.1-20.0ng/ml?in?Chinese?men.?Urol?Oncol.?2011?Aug?23.?[Epub?ahead?of?print]?(IF?3.172)2.?Tang?P,?Du?W,?Xie?K,?et?al.?Characteristics?of?baseline?PSA?and?PSA?velocity?in?young?men?without?prostate?cancer:?Racial?differences.?Prostate.?201272(2):173-80.?(IF?3.377)3.?Tang?P,?Sun?L,?Uhlman?MA,?et?al.?Prostate-Specific?Antigen?Velocity?Based?Risk-Adapted?Discontinuation?of?Prostate?Cancer?Screening?in?Elderly?Men.?BJU?Int.?2011?108?(1):?44-48.?(IF?3.190)4.?Tang?P,?Sun?L,?Uhlman?MA,?et?al.?Baseline?PSA?as?a?predictor?of?prostate?cancer-specific?mortality?over?the?past?2?decades:?duke?university?experience.?Cancer.?2010?116(20):4711-4717.?(IF?5.131)5.?Tang?P,?Xie?KJ,?Wang?B,?et?al.?Antibacterial?therapy?improves?the?effectiveness?of?prostate?cancer?detection?using?prostate-specific?antigen?in?patients?with?asymptomatic?prostatitis.?Int?Urol?Nephrol.?2010?42(1):13-18.?(IF?1.567)6.?Tang?P,?Sun?L,?Uhlman?MA,et?al.?Initial?prostate?specific?antigen?1.5?ng/ml?or?greater?in?men?50?years?old?or?younger?predicts?higher?prostate?cancer?risk.?J?Urol.?2010?183(3):946-950.?(IF?3.862)7.?Tang?P,?Sun?L,?Uhlman?MA,?et?al.?Prostate-specific?Antigen-based?Risk-adapted?Discontinuation?of?Prostate?Cancer?Screening?in?Elderly?African?American?and?Caucasian?American?Men.?Urology.?2010?76(5):1058-1062.?(IF?2.334)8.?Moul?JW?,?Tang?P,??Sun?L.?Editorial?Comment?on:?Development?of?a?New?Method?for?Monitoring?Prostate-Specific?Antigen?Changes?in?Men?with?Localised?Prostate?Cancer:?A?Comparison?of?Observational?Cohorts.?Eur?Urol.?2010?57(3):452.?(IF?8.843)??